INOVIO Pharmaceuticals shares surged more than threefold in pre-market trading after the US Food and Drug Administration approved a drug to treat rare respiratory conditions.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.